Results
1
-
1
of
1
Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach.
[DOI: 10.1016/j.ejmech.2012.10.050]